Suffering from Psoriasis? New Clinical Trial

NOW ENROLLING – NEW Psoriasis Clinical Trial

Do you know anyone suffering from psoriasis? Call Today – 855.554.6374

Clinical Trial Government Identifier #NCT03635099

Sponsor: Boehringer Ingelheim

Genders eligible for study: Male/Female Ages eligible for study: 18 years and older
NEW STUDY – Moderate to Severe plaque psoriasis present for at least 6 months;
Body mass index (BMI) must be less than 35
November 2018 – TBD
**This is an oral medication.

note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.